Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Blueprint Medicines: Q1 Earnings Snapshot AP - Thu May 2, 6:11AM CDT

Blueprint Medicines: Q1 Earnings Snapshot

BPMC : 111.18 (+1.97%)
Blueprint Medicines: Q4 Earnings Snapshot AP - Thu Feb 15, 6:26AM CST

Blueprint Medicines: Q4 Earnings Snapshot

BPMC : 111.18 (+1.97%)
BPMC
Chart of the Day: Does Blueprint Medicines Have a Blueprint for Success? Barchart - Wed Dec 13, 2023

The Chart of the Day belongs to the cancer biomedical company Blueprint Medicines (BPMC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical...

BPMC : 111.18 (+1.97%)
Why Blueprint Medicines Stock Soared Today Motley Fool - Thu Oct 26, 2023

The precision-treatment company saw stronger-than-expected sales in its first full quarter following the launch of Ayvakit.

BPMC : 111.18 (+1.97%)
Blueprint Medicines: Q3 Earnings Snapshot AP - Thu Oct 26, 2023

Blueprint Medicines: Q3 Earnings Snapshot

BPMC : 111.18 (+1.97%)
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Thu Oct 5, 2023

/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective October 1, 2023, the Compensation Committee of Blueprint...

BPMC : 111.18 (+1.97%)
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective September 1, 2023, the Compensation Committee of Blueprint...

BPMC : 111.18 (+1.97%)
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire - Fri Aug 4, 2023

/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective August 1, 2023, the Compensation Committee of Blueprint...

BPMC : 111.18 (+1.97%)
Why Shares of Blueprint Medicines Are Falling Wednesday Motley Fool - Wed Aug 2, 2023

The company had generally improved earnings.

BPMC : 111.18 (+1.97%)
Blueprint Medicines: Q2 Earnings Snapshot AP - Wed Aug 2, 2023

Blueprint Medicines: Q2 Earnings Snapshot

BPMC : 111.18 (+1.97%)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024 Barchart - 13 minutes ago
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot